AS THE LEGISLATION ON THE PROMOTION OF PHARMACEUTICALS IS GRADUALLY BECOMING STRICTER WORLDWIDE, AND SOCIETY IS INCREASINGLY EXPECTING ORGANISATIONS TO OPERATE TRANSPARENTLY, MEDITOP PHARMACEUTICALS LTD. IS FULLY COMMITTED TO THE VALUES OF TRANSPARENCY, ETHICAL BEHAVIOUR AND PATIENT-CENTREDNESS IN ITS BUSINESS ACTIVITIES.
The Transparency Initiative aims to increase transparency and trust and to promote patient-centredness by making the financial relationship between the pharmaceutical industry and healthcare professionals and providers/organisations transparent, as outlined above. MEDITOP Pharmaceutical Ltd. has joined the introduction of the new self-regulatory directive as a member company of MAGYOSZ.
Under the Generic Transparency Code, MEDITOP Pharmaceuticals Ltd. is required to document all benefits it provides directly or indirectly to or for the benefit of a healthcare professional, healthcare organisation or patient organisation and to publish them on its website.
The Code aims to establish globally acceptable standards and principles for generic pharmaceutical companies that promote trust, responsibility and respect between pharmaceutical companies and the healthcare community, including healthcare professionals, healthcare organisations, patients and patient organisations.